Patent · US Active

UTI fusion proteins

US10351618B2 · kind B2 · utility

1Cited by

7References

16Claims

0Family size

Assignee

Takeda Pharmaceutical Company Limited · JP

Inventors

Aaron Keith Chamberlain · San Diego, US
Qiang Liu · Saskatoon, CA
Mathias Schmidt · Idstein, DE

Key dates

Filing date	Nov 27, 2017
Grant date	Jul 16, 2019
Priority date	—
Expiry date	Nov 27, 2037

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides UTI fusion proteins, DNA sequences for producing the same, and pharmaceutical compositions and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.